This webinar presentation provided an overview of practical steps for selecting and implementing an electronic trial master file (eTMF). It began with an introduction and housekeeping items. It then covered the changing regulatory landscape around eTMF requirements. Key challenges and the future of eTMF were discussed. The presentation outlined the process for eTMF vendor selection and provided tips for a successful implementation. It emphasized the importance of planning, change management, and adopting the TMF Reference Model.
Six Elements of the QC Process.
To learn more about the QC Process join us for a complimentary webinar ( March 29 @11am EST) where we will follow a TMF document through its life cycle from creation through inspection: Learn how TMF documents should maneuver through TMF submissions and quality checks utilizing well-developed processes, tools and metrics to ensure the TMF is ready when the inspectors come knocking.
Presented by: Jackie Morrill - Director of Clinical Operations
Register Here: http://bit.ly/2kqA6s8
This presentation describes a case study of an eTMF structure, setup, and implementation at a biotechnology company currently conducting a pivotal Phase 3 clinical study in 70 centers worldwide.
Advance Information Management Through eTMF and CTMS ConvergenceWingspan Technology
With the increasing need for oversight of studies taking place across the globe, effective TMF management through an eTMF is just the tip of the iceberg for enhancing your organizations’ collaboration strategies. By utilizing an eTMF in conjunction with a CTMS, the opportunity to improve management of information is afforded.
Transforming eTMF Management: Moving to a Data-Driven ApproachMontrium
We are moving towards a digital age of automation in clinical trials where electronic management of content and data to document activities and decisions is the industry-wide norm.
This means that the concept of TMF is also evolving and is no longer just a document repository, but rather a collection of systems holding content and data. As a result, there is a strong business case from moving away from just archiving documents to actively managing TMF content and information using techniques and practices borrowed from clinical data management.
In this webinar, we will look at how you can use queries, data review and process-based approaches to ensure that your TMF tells an accurate and complete story of what occurred in your study. We will also discuss the greater scope of TMF relevant information and systems and how you can best integrate these sources into a more holistic environment to greatly facilitate inspections and clinical trial oversight.
Life science companies expect electronic trial master file (eTMF) projects to provide greater efficiency, improve quality, increase standardization and enhance collaboration in TMF management. Join Paragon Solutions for the second session of our TMF webinar series to gain insights on the practical factors to consider when planning a new or improved future state eTMF. We'll share industry data on eTMF drivers, and discuss our definition of a robust eTMF. You'll learn why TMF information architecture is so critical to eTMF uptake and usability, and high level considerations for systems integration/migration. Finally, we'll define the maturity framework that allows for assessment of eTMF organizational readiness, a critical baseline to successful future state eTMF planning.
Using Vault eTMF Milestones and EDLs to Support Inspection ReadinessVeeva Systems
Hear how Daiichi Sankyo is using milestones and expected document lists (EDLs) to enable ongoing inspection readiness and proactive TMF management and oversight.
Six Elements of the QC Process.
To learn more about the QC Process join us for a complimentary webinar ( March 29 @11am EST) where we will follow a TMF document through its life cycle from creation through inspection: Learn how TMF documents should maneuver through TMF submissions and quality checks utilizing well-developed processes, tools and metrics to ensure the TMF is ready when the inspectors come knocking.
Presented by: Jackie Morrill - Director of Clinical Operations
Register Here: http://bit.ly/2kqA6s8
This presentation describes a case study of an eTMF structure, setup, and implementation at a biotechnology company currently conducting a pivotal Phase 3 clinical study in 70 centers worldwide.
Advance Information Management Through eTMF and CTMS ConvergenceWingspan Technology
With the increasing need for oversight of studies taking place across the globe, effective TMF management through an eTMF is just the tip of the iceberg for enhancing your organizations’ collaboration strategies. By utilizing an eTMF in conjunction with a CTMS, the opportunity to improve management of information is afforded.
Transforming eTMF Management: Moving to a Data-Driven ApproachMontrium
We are moving towards a digital age of automation in clinical trials where electronic management of content and data to document activities and decisions is the industry-wide norm.
This means that the concept of TMF is also evolving and is no longer just a document repository, but rather a collection of systems holding content and data. As a result, there is a strong business case from moving away from just archiving documents to actively managing TMF content and information using techniques and practices borrowed from clinical data management.
In this webinar, we will look at how you can use queries, data review and process-based approaches to ensure that your TMF tells an accurate and complete story of what occurred in your study. We will also discuss the greater scope of TMF relevant information and systems and how you can best integrate these sources into a more holistic environment to greatly facilitate inspections and clinical trial oversight.
Life science companies expect electronic trial master file (eTMF) projects to provide greater efficiency, improve quality, increase standardization and enhance collaboration in TMF management. Join Paragon Solutions for the second session of our TMF webinar series to gain insights on the practical factors to consider when planning a new or improved future state eTMF. We'll share industry data on eTMF drivers, and discuss our definition of a robust eTMF. You'll learn why TMF information architecture is so critical to eTMF uptake and usability, and high level considerations for systems integration/migration. Finally, we'll define the maturity framework that allows for assessment of eTMF organizational readiness, a critical baseline to successful future state eTMF planning.
Using Vault eTMF Milestones and EDLs to Support Inspection ReadinessVeeva Systems
Hear how Daiichi Sankyo is using milestones and expected document lists (EDLs) to enable ongoing inspection readiness and proactive TMF management and oversight.
Presentation from the 2016 MAGI West conference on how to prepare your organization for inspection readiness by focusing on processes, governance, and tools.
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...Montrium
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Since its release in 2010, The DIA’s TMF Reference Model has proven to be extremely valuable to the life sciences industry. In this content-packed webinar, we will provide a history and overview of the Model, present its structure, and the various sub-groups and resources available. The Model is not intended to be used “off-the-shelf" but can be implemented according to certain expectations and requirements of life science sponsors (pharma, bio, device), investigative sites (academic, for-profit, nonprofit) and CROs / third-party team members alike.
Paul Fenton, CEO of Montrium and CGI Life Science’s Fran Ross, both Members of the TMF Reference Model Steering Committee, will discuss strategies for implementing the Model and how it can be used to ensure tight controls of GxP required content for inspection. Finally, the session will present the TMF Reference Model Exchange Mechanism Standard which extends the Model's capability to facilitate eTMF interoperability and content exchange.
Review of essential documents (TMF BABE).Piyush Wagh
This ppt is useful for the Clinical Auditors (BABE), it helps in reviewing of essential documents and compilation of essential documents during clinical phase. Bioequivalence
Implementing Metrics & Completeness Reporting in TMF ManagementMontrium
Completeness is a key measurement for TMF to assess inspection readiness, however most organizations and eTMF systems are unable to calculate it accurately. The reason for this is primarily due to a lack of information or knowledge of study design and events that have occurred or that will occur in the study.
In this webinar, we will discuss strategies for calculating accurate completeness as well as review other key metrics that enable you to assess your TMF health and inspection readiness.
Investigators Responsibilities during Clinical trialsBHAVYARAJAN2
This Presentation was presented by Pruthvi raj, Tejaswini, and myself Bhavya Rajan at Clinosol Research Pvt Ltd. We would like to thank Clinosol and Mujeeb sir for this opportunity. for constantly supporting and encouraging us
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Clireo eTMF Solution by Arivis
What is Clireo?
• Comprehensive Software and Service enabling the Trial Master File
• Compliant with the DIA Trial Master File Reference Model Version 3
• Assign access and maintain control of Sites, Vendors, and Auditors for content.
• Eliminate CRA need to reconcile the Investigator Site File against the Sponsor TMF.
• Part 21 CFR 11 Digital signatures allow for faster turn around time on documents.
• Ability to quickly disseminate new information to users that the information is relevant to.
• Vendors and Sites can upload documentation and data directly into Clireo.
• Unlimited storage capacity assures that all documentation can be held in one location.
• No additional hardware required to implement.
• Dashboard reports on the status of sites and documents to easily identify missing or lagging information.
• Protect documents against unauthorized modification.
• Supports single or multiple file uploads with single screen metadata tagging.
• Centralized Documentation-Access from Anywhere.
• Resolve document issues faster.
• Ability to search documents in many ways.
• Dramatic Reduction in the need to print, scan, and store multiple copies in several locations.
• Link documents together to create a complete document package.
We have been serving eTMF customers since 2007.
Email now to schedule a demonstration and see how Clireo and Arivis can help you with your eTMF needs.
Tricia McQuarrie
Clinical Operations Manager tricia.mcquarrie@arivis.com
Arivis, Inc.
2198 E. Camelback Road
Phoenix, AZ 85016
Tel. 602-957-2150
www.m3.arivis.com
In our upcoming webinar, we will be exploring how dividing responsibilities between CRO and Sponsor in an outsourcing model can be leveraged to improve the quality of your trials. We'll start by diving in to the world of outsourcing and what roles different organizations can play, and then explore some of the ways technology can enable outsourced TMF management to operate smoothly.
Learn what inspectors are looking for and how to prepare for inspections in eTMF. This deck will cover an inspections overview, inspection preparation, inspector access, and inspection readiness. For more info, visit http://bit.ly/VaulteTMF
The way we manage the TMF is constantly evolving. Regulations are often catalysts to change in the eTMF space and staying on top of industry trends is vital in making sure you are working in the best possible way.
In our presentation, we will be exploring 5 of the hottest trends in the future of eTMF which include interoperability, traceability and data integrity, challenges of inspection when data is spread in multiple systems, and how the industry would be affected by the potential ratification of the TMF Reference Model by ICH.
We will also dive deeper into the inner workings of these trends and how we can begin to solve some of these issues which are spreading in the industry.
The presentation covers the following topics:
- Where the industry is today regarding eTMF
- What regulatory bodies are initiating change in the clinical space
- How the ICH is a catalyst to change in the TMF reference model
- Traceability and data integrity in today's model
- Challenges of inspection with disparate systems
- Interoperability and the future of eTMF
- Plus much more...
Follow along via our webinar:
https://info.montrium.com/the-future-of-etmf-actionable-industry-trends-and-insights
Integrating and appling tmf regulation into your buisness processMontrium
How will you navigate the new TMF regulatory landscape?
Many organizations today still struggle to develop effective compliance strategies. In recent years we have seen a dramatic change in pace from regulatory authorities and standards organizations. With a wealth of new updates coming in, it is becoming increasingly more complex to remain compliant. With this in mind, our upcoming webinar will focus on the recent regulatory changes that will impact trial master files and provide a practical outlook on how to apply them and stay one step ahead.
Presentation from the 2016 MAGI West conference on how to prepare your organization for inspection readiness by focusing on processes, governance, and tools.
TMF Fundamentals - An Introduction to Better Trial Master File Management - M...Montrium
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Since its release in 2010, The DIA’s TMF Reference Model has proven to be extremely valuable to the life sciences industry. In this content-packed webinar, we will provide a history and overview of the Model, present its structure, and the various sub-groups and resources available. The Model is not intended to be used “off-the-shelf" but can be implemented according to certain expectations and requirements of life science sponsors (pharma, bio, device), investigative sites (academic, for-profit, nonprofit) and CROs / third-party team members alike.
Paul Fenton, CEO of Montrium and CGI Life Science’s Fran Ross, both Members of the TMF Reference Model Steering Committee, will discuss strategies for implementing the Model and how it can be used to ensure tight controls of GxP required content for inspection. Finally, the session will present the TMF Reference Model Exchange Mechanism Standard which extends the Model's capability to facilitate eTMF interoperability and content exchange.
Review of essential documents (TMF BABE).Piyush Wagh
This ppt is useful for the Clinical Auditors (BABE), it helps in reviewing of essential documents and compilation of essential documents during clinical phase. Bioequivalence
Implementing Metrics & Completeness Reporting in TMF ManagementMontrium
Completeness is a key measurement for TMF to assess inspection readiness, however most organizations and eTMF systems are unable to calculate it accurately. The reason for this is primarily due to a lack of information or knowledge of study design and events that have occurred or that will occur in the study.
In this webinar, we will discuss strategies for calculating accurate completeness as well as review other key metrics that enable you to assess your TMF health and inspection readiness.
Investigators Responsibilities during Clinical trialsBHAVYARAJAN2
This Presentation was presented by Pruthvi raj, Tejaswini, and myself Bhavya Rajan at Clinosol Research Pvt Ltd. We would like to thank Clinosol and Mujeeb sir for this opportunity. for constantly supporting and encouraging us
In this presentation, we explore the TMF fundamentals and an introduction to better managing your TMF. We'll start by diving into the world of TMF management, how to properly leverage the regulations, which documents constitute as TMF-worthy and what basic metrics you can track to increase the efficiency of your trial.
Finally, we will also discuss some of the features Montrium has developed to facilitate the management of the Trial Master File in a fundamental way.
This presentation covers the following topics:
-Fundamentals of TMF management process
-How to use the regulations to ensure success
-What cross functional groups hold TMF worthy documents
-TMF management challenges and how you can alleviate them
-Base metrics to track and what they mean to your organization
-How an eTMF helps TMF Management
You can follow along with this presentation via our webinar:
https://info.montrium.com/tmf-fundamentals-an-introduction-to-better-trial-master-file-management
Clireo eTMF Solution by Arivis
What is Clireo?
• Comprehensive Software and Service enabling the Trial Master File
• Compliant with the DIA Trial Master File Reference Model Version 3
• Assign access and maintain control of Sites, Vendors, and Auditors for content.
• Eliminate CRA need to reconcile the Investigator Site File against the Sponsor TMF.
• Part 21 CFR 11 Digital signatures allow for faster turn around time on documents.
• Ability to quickly disseminate new information to users that the information is relevant to.
• Vendors and Sites can upload documentation and data directly into Clireo.
• Unlimited storage capacity assures that all documentation can be held in one location.
• No additional hardware required to implement.
• Dashboard reports on the status of sites and documents to easily identify missing or lagging information.
• Protect documents against unauthorized modification.
• Supports single or multiple file uploads with single screen metadata tagging.
• Centralized Documentation-Access from Anywhere.
• Resolve document issues faster.
• Ability to search documents in many ways.
• Dramatic Reduction in the need to print, scan, and store multiple copies in several locations.
• Link documents together to create a complete document package.
We have been serving eTMF customers since 2007.
Email now to schedule a demonstration and see how Clireo and Arivis can help you with your eTMF needs.
Tricia McQuarrie
Clinical Operations Manager tricia.mcquarrie@arivis.com
Arivis, Inc.
2198 E. Camelback Road
Phoenix, AZ 85016
Tel. 602-957-2150
www.m3.arivis.com
In our upcoming webinar, we will be exploring how dividing responsibilities between CRO and Sponsor in an outsourcing model can be leveraged to improve the quality of your trials. We'll start by diving in to the world of outsourcing and what roles different organizations can play, and then explore some of the ways technology can enable outsourced TMF management to operate smoothly.
Learn what inspectors are looking for and how to prepare for inspections in eTMF. This deck will cover an inspections overview, inspection preparation, inspector access, and inspection readiness. For more info, visit http://bit.ly/VaulteTMF
The way we manage the TMF is constantly evolving. Regulations are often catalysts to change in the eTMF space and staying on top of industry trends is vital in making sure you are working in the best possible way.
In our presentation, we will be exploring 5 of the hottest trends in the future of eTMF which include interoperability, traceability and data integrity, challenges of inspection when data is spread in multiple systems, and how the industry would be affected by the potential ratification of the TMF Reference Model by ICH.
We will also dive deeper into the inner workings of these trends and how we can begin to solve some of these issues which are spreading in the industry.
The presentation covers the following topics:
- Where the industry is today regarding eTMF
- What regulatory bodies are initiating change in the clinical space
- How the ICH is a catalyst to change in the TMF reference model
- Traceability and data integrity in today's model
- Challenges of inspection with disparate systems
- Interoperability and the future of eTMF
- Plus much more...
Follow along via our webinar:
https://info.montrium.com/the-future-of-etmf-actionable-industry-trends-and-insights
Integrating and appling tmf regulation into your buisness processMontrium
How will you navigate the new TMF regulatory landscape?
Many organizations today still struggle to develop effective compliance strategies. In recent years we have seen a dramatic change in pace from regulatory authorities and standards organizations. With a wealth of new updates coming in, it is becoming increasingly more complex to remain compliant. With this in mind, our upcoming webinar will focus on the recent regulatory changes that will impact trial master files and provide a practical outlook on how to apply them and stay one step ahead.
Empowering Active TMF Management With an eTMF SystemMontrium
Active TMF Management is critical when conducting a trial. Managing your trial documentation on an on-going basis will allow organizations to have greater oversight on the completeness, empower team members to submit content in timely manner, and ultimately be continuously inspection ready all the while monitoring the quality of your documents.
In our upcoming webinar, we will be exploring how to use an eTMF system to its full capacity by empowering active TMF Management. We'll start by understanding the measurable benefits gained by managing an active TMF and the disadvantages of having a passive TMF repository.
We will also dive deeper into some of the features Montrium has developed as part of our eTMF which empowers clinical teams and gives organization's the tool to have a successful study.
During this webinar, you'll learn:
• What challenges are present when using an eTMF solely as a repository?
• What it means to have active TMF Management with an eTMF System
• How to empower clinical teams to collaborate and treat TMF as a living document
• What tools an eTMF provides to allow for active management
• What benefits active TMF management provides
• Introduction to Montrium's eTMF
• Plus much more...
The Webinar will cover the following topics:
• What challenges are present when using an eTMF solely as a repository?
• What it means to have active TMF Management with an eTMF System
• How to empower clinical teams to collaborate and treat TMF as a living document
• What tools an eTMF provides to allow for active management
• What benefits active TMF management provides
• Introduction to Montrium's eTMF
• Plus much more...
10-3 Clinical Informatics System Selection & ImplementationCorinn Pope
Section ten, module three of the clinical informatics course discusses the information system lifecycle. In this slide deck, we'll cover how to pick a clinical information system that works best for you. Also included are three free practice questions. If you would like more information or resources, be sure to check out our site at http://www.informaticspro.com.
Best practices for preparing for and surviving inspectionsMontrium
Inspections are the apex of the clinical trial. It is something that we prepare, plan for and ultimately dread for the entire duration of the study. Being inspection ready can take a significant burden off your clinical team, maximize time and get your product to market faster.
In our upcoming webinar, we will be exploring the best practices for preparing and surviving TMF inspections. We'll start by diving into why inspection readiness should be continuous, and some key strategies to ensure your team has a successful inspection.
We will also dive deeper into some of the tools Montrium has developed that give your clinical teams an edge when it comes to surviving inspections, and providing your team greater oversight into eTMF completeness.
The Webinar will cover the following topics:
• Why is preparing for inspections important?
• What are some of the challenges organizations face when it comes to inspections?
• Why is it difficult to be inspection ready at all times?
• Best practices when preparing for an upcoming inspection
• How to survive the inspector
• Introduction to Montrium's eTMF
• Plus much more...
Automation of document management paul fenton webinarMontrium
In the life sciences, most of the documents we create end up as records. Now, as we move towards a paperless era in today’s GxP environment and leverage digital content management technology, we are also starting to change the way that we author, collaborate, manage, exchange, and archive our documents.
The very nature of document management is transforming as more and more data becomes part of the document management landscape. In this webinar, we explore how technology is transforming our GxP records management environments and what the future may hold for automating processes
Best practices for preparing for and surviving inspectionsMontrium
We will be exploring the best practices for preparing and surviving TMF inspections. We'll start by diving into why inspection readiness should be continuous, and share some key strategies to ensure your team has a successful inspection.
Document Management in the Life Sciences - New Horizons for Small-Medium Ente...Montrium
Efficient management of documentation is key to the successful development of new molecules. It is also often one of the most challenging aspects of managing a clinical program. There are efficiencies to be had through the use of an electronic system compared to paper, however, these systems can be time consuming and expensive to put in place. This webinar will focus on the challenges and opportunities that small to medium enterprises face when trying to improve their document management processes within the context of clinical trials.
Topics will include:
• Where we have come from and where we are today
• Drivers to adopt electronic document and records management
• Changing regulatory expectations
• What are my options – Paper, On-Premise, Cloud
• Benefits of a structured approach to EDM
• Document Management Challenges faced by SMEs
• Montrium’s approach to delivering Document Management for the Life Sciences in the cloud
• Future Trends in Records Management
Best practices for preparing for and surviving inspectionsMadison Ramsay
We will be exploring the best practices for preparing and surviving TMF inspections. We'll start by diving into why inspection readiness should be continuous, and share some key strategies to ensure your team has a successful inspection.
Best practices for preparing for and surviving inspectionsMontrium
We will be exploring the best practices for preparing and surviving TMF inspections. We'll start by diving into why inspection readiness should be continuous, and share some key strategies to ensure your team has a successful inspection.
Strategies for Conducting GxP Vendor Assessment of Cloud Service Providers - ...Montrium
Want to deploy a new technology solution but not sure where to begin? These slides cover key considerations for choosing a vendor with cloud compliance and validation in mind. With the Office 365 subscription-based service gaining considerable momentum in the life sciences, it's important to stay ahead of the technological and regulatory curve and consider how an EDMS system will bring improvements to managing your GxP content.
Here we cover the following topics:
-Vendor assessment of Microsoft
-Subscription basics of Office 365
-Review of ISO/SOC audit reports
-Ensuring that no critical observations are made
-Security and quality controls in place
You can follow along with this presentation via webinar format:
https://info.montrium.com/strategies-for-conducting-gxp-vendor-assessment-of-cloud-service-providers
10 Things to Consider When Building a CTMS Business CasePerficient, Inc.
Sponsors and research organizations are often tasked with building a business case for a clinical trial management system (CTMS) before they even evaluate the various solutions in the marketplace.
After multiple successful Oracle Siebel CTMS implementations, Perficient has identified 10 ways you can benefit from a CTMS solution.
In this slideshare we share information that you can leverage as you develop a business case for a CTMS.
We also demonstrate the two most popular CTMS benefits and corresponding features.
Best Practices for Managing Regulatory Binders ElectronicallyVeeva Systems
- Industry drivers for change and benefits of eRegulatory
- Tips for choosing the right system and evaluating a vendor
- Best practices and mistakes to avoid when going electronic
Are you involved with planning tech transfer of your drug product? Join this webinar to learn more about the regulations and considerations you need to consider and learnings from a case study.
According to ICH Q10, “The goal of technology transfer activities is to transfer product and process knowledge between development and manufacturing, and within or between manufacturing sites to achieve product realization. This knowledge forms the basis for the manufacturing process, control strategy, process validation approach, and ongoing continual improvement.”
As a result, there is an expectation for transfers to be performed in an organized, methodical manner with appropriate documentation. It is also expected that they happen between one Process Development group to another or to a Pilot Lab, from Process Development lab to clinical or commercial manufacturing, or from Process Development to external clinical manufacturing. Lastly, they may also happen between two company facilities at commercial scale, or between a company and an external contract manufacturing at commercial scale.
This presentation will cover points to consider for successful tech transfers with a focus on cGMP training requirements, and include lesson learned from real cases.
Presented by Guillaume Plane on September 22, 2016
Similar to Practical Steps to Selecting and Implementing an eTMF (20)
Monitoring Beyond COVID-19: Setting Yourself Up for the New-NormalMontrium
The Covid-19 pandemic has forced the pharmaceutical and medical device industries to explore methods beyond the traditional on-site monitoring and auditing of clinical trial sites. It has enabled companies to leverage both existing technologies and quickly adopt new methodologies to ensure data integrity and patient safety.
With these changes, companies are able to identify opportunities for both increased quality and efficiencies in their clinical trials.
In this webinar, we will discuss:
Opportunities and the challenges of the “new normal” in the management and oversight of clinical trials
Insights into how we think technology will evolve in the future to better support new risk based approaches to oversight
AI's growing role in clinical trial oversight
Best Practices for Implementing Robust Governance Processes in Office 365Montrium
With Office 365 cloud services, it’s up to customers to manage GxP data governance, authorize access, and configure settings to ensure data integrity. However, given Office 365’s highly customizable nature, many teams face frustrations when establishing governance provisions.
To combat the challenges that come with a continuously evolving system, we will share how you can establish/adapt governance processes to accommodate for smaller, frequent changes. During the webinar, you will learn how Office 365 customers' data benefits from having multiple layers of granular control within a robust governance model to support the management of GxP content.
The webinar covers the following topics:
Overview of IT Governance
Risk-based approach tied to Governance: identifying and mitigating risks in the cloud
Methodology for a good Office 365 Governance strategy
Office 365 Governance with Technical Controls
Compliance Monitoring Overview
Strategies to Facilitate GxP Processes Deployment in Office 365Montrium
Moving your existing environment to manage regulated content in a new Office 365 environment requires a rigorous amount of attention to detail, and any overlook can lead to more significant problems down the road. Whether you’re coming from working within legacy applications or pre-existing infrastructure, you must take the right precautions.
When deploying GxP processes in Office 365, you will need to leverage a deployment approach that can address both technical considerations while accounting for the distinctions in your organizational culture and specific user requirements.
How to Get Started with GxP Processes in Office 365 - The Discovery PhaseMontrium
The webinar covers the following topics:
-How the GxP Design and Delivery Landscape is Changing (digitization of processes, cloud adoption, agile adaptation, better relationships with service providers)
-Business Analysis for Office 365 and the Cloud (methods applied in a Discovery that meet life science trends)
-Discovery Goals (relationships, vision, delivery and enablement of GxP solutions in Office 365)
-Discovery Walkthrough (methodology, sessions, best practices)
How to prepare for an audit and maintain oversight within your e qmsMontrium
In this webinar, not only will we take you through what you’ll need to do to prepare for an audit, but we will also share what you can do to contribute to continuously improve and maintain oversight of your QMS.
With Office 365 cloud services, it’s up to customers to manage data governance, authorize access, and configure settings to ensure data integrity. Montrium's Professional Services team has extensive experience working to mitigate the frustrations that teams face when establishing governance provisions for Office 365.
In this webinar, your host Chrysa will discuss how Office 365 customers' data benefits from having multiple layers of granular control within a robust governance model to support the management of GxP content.
-The webinar will cover the following topics:
-Office 365 governance strategy and model overview
-Documents that contribute to SharePoint Online governance
-Governance considerations for GxP and non-GxP use
-Identifying and mitigating risks in the cloud
-And much more...
Over 5 unique webinar sessions, we’ll share everything you need to know about transitioning to Office 365 and SharePoint Online. These webinars will feature actionable strategy, exemplified by real-world case studies, and practical game plans to help you develop a clear strategy for managing GxP content in the cloud.
The Compliance Playbook Webinar Series is geared towards those looking to migrate from file shares and other legacy EDMS systems - to becoming more agile with Office 365.
We'll take you through:
- Why are Life Sciences Organizations moving to Office 365
- Strategies for Conducting Vendor Assessments of Cloud Vendors
Validation in Office 365: Tools for Acceleration
- Validation in Office 365: Continuous Validation
- Maintaining Oversight for Complete Governance in Office 365
Tools for Accelerating Validation of Office 365Montrium
It can be overwhelming navigating the evolving requirements pertaining to records management in electronic systems, even for the more experienced validation veteran. In this presentation, discover key insights on Office 365 validation to serve your clinical and regulatory needs.
Ultimately, the responsibility to validate GxP applications is on customers and partners of Microsoft - so we take a look at how to build out a validation plan and control protocols for successful integration with your existing system.
We uncover how Office 365 satisfies specifications of FDA’s 21 CFR Part 11 and EU Annex 11 from both a procedural and technical approach to satisfy regulatory conditions, and how the balance of shared responsibilities between Microsoft and its life sciences customers can satisfy regulatory requirements.
Develop a clearer overview of how to adapt validation techniques to the cloud, as well as key validation expectations and deliverables in Office 365.
The presentation covers the following topics:
-Preparation and adaptation of validation deliverables
-How to build a validation plan: scope and risk rationale
-Risk-based validation planning
-Regulatory compliance impact assessments for Office 365
-Components to be qualified and validated in the cloud
-Developing a validation summary report
Why Are Life Science Companies Moving to Office 365?Montrium
The webinar will cover the following topics:
-Moving away from costly and inefficient legacy systems
-Key GxP features and capabilities available in the cloud
-Case studies of Office 365 across the life sciences landscape
-What comes with a continuous Office 365 Validation Subscription?
-Montrium methodology, tools, and documentation available to you
Automating the Regulatory Submission Process - Reducing Time and Increasing Q...Montrium
In this presentation, we will be exploring how technology can be leveraged to improve submission readiness and the quality of your electronic submissions. Discover why planning submissions is important, and examine some of the key components of a successful submission readiness plan.
Follow along via webinar format:
https://info.montrium.com/webinar-automating-the-regulatory-submission-process
In this presentation, we explore the ways you can get internal buy-in and how to build out your business case. We will start by breaking down an eTMF business case and going through the sections you’ll need to include to have a successful meeting internally.
Follow along via our webinar:
https://info.montrium.com/webinar-how-to-build-the-business-case-for-an-etmf-system
Whether it’s meeting the next big client, forming your next business partnership, learning new skills, getting advice from peers, or keeping up with industry information, the return on investment of attending the right events can be substantial.
As a technology vendor that regularly exhibits, speaks and advises clinical conferences all over the world, we’ve seen and attended our fair share of fantastic, and not so fantastic industry conferences. Let’s be honest, there are hundreds of conferences scattered on every continent, but which one is going to give you the best return for your time and money? We’ve laid out our list of top conferences to attend in 2019 that will make you want to start packing today.
The ability to meet standards and regulatory approval is nowhere more important than in the pharmaceutical industry. All companies have responsibilities when it comes to submitting information to authorities in both a precise and proper manner as, otherwise, their latest developments and innovations could be held back by dreaded red tape.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
4. 4
House
Keeping
L I V E W E B I N A R
• This webinar is being recorded and
will be made available after this
session
• Feel free to use the chatbox to
submit your questions at anytime
• Q&A will take place at the end of the
webinar
• We will send these slides to your
email at the end of the webinar
6. • Founded in 2005
• Working Exclusively in the Life Sciences
• Headquartered in Montreal, Canada
• EU HQ in Brussels
• Clients in North America, Europe & Asia
• Leading Content Management Platform
• Over 8000 Users in 20+ Countries
• Experienced Professional Services Group
6
About
Montrium
Connecting People,
Processes & Technology
A B O U T T H E C O M P A N Y
7. 7
Electronic Content
Management & Business
Intelligence for Clinical
Trials
C O N N E C T P L A T F O R M
Regulatory Document
Management & Submission
Planning for Drugs and
Devices
Integrated and Data Driven
Quality Management
Solutions for Life Sciences
9. 9
Regulatory
evolution –
EMA Guideline
Guideline on the content,
management and archiving of
the clinical trial master file (paper
and/or electronic)
EMA/INS/GCP/856758/2018
Released 6 December 2018
• Legislation does not differentiate between paper
and electronic TMF
• TMF content should be collated in a timely manner
• GCP Inspectors will require direct access to the
eTMF system as used by the organization
• There should be a primary TMF system for holding
essential documents
• Information contained within other systems may
also be considered part of the TMF
10. 10
Regulatory
Evolution - New
EU Directive
• EU Regulation 536/2014 originally released in 2014,
will likely come into effect in 2019
• The sponsor and investigator shall keep a clinical
trial master file….it shall be readily available and
directly accessible upon request.
• The sponsor and the investigator shall archive the
content of the clinical trial master file for at least 25
years after the end of the clinical trial
11. 11
Regulatory
Evolution - ICH
E6 Addendum
R2
• Currently in step 4 (consultation) of the ICH process
and is currently being implemented by ICH
members
• The sponsor and investigator/institution should
maintain a record of the location(s) of their
respective essential documents. The storage
system (irrespective of the media used) should
provide for document identification, search and
retrieval.
12. 12
Regulatory
Evolution - ICH
E6 Addendum
R2
• SOPs should cover system setup, installation
and use. The SOPs should describe:
System validation and functionality testing
Data collection and handling
System maintenance
System security measures
Change control
Data backup and recovery
Contingency planning
Decommissioning
• The responsibilities of the sponsor,
investigator and other parties with respect to
the use of these computerized systems
should be clear, and the users should be
provided with training in the use of the
systems
13. ü That the eTMF is able to demonstrate
compliance with the protocol and GCP
ü That the eTMF is up to date and readily
available for inspection directly within the
system
ü That minimal training is required to access
the system and find eTMF content
ü That a clear inventory of eTMF content
exists and identifies what content is being
maintained where
ü That systems are adequately validated
and controlled
ü That copies of paper records maintained
within the eTMF are certified copies
13
What the
Regulators
Expect from
eTMF
14. • Approach can vary between different
inspectorates
• In EU, inspectors want to be able to access
the complete eTMF in the organizations
system
• They should be able to search for content,
and review eTMF preferably in a book like
fashion
• They want to be able to flag documents for
later review
• They want to be able to see documents on-
screen easily
• They potentially want to perform remote
review of documents
• They will expect to be able to access other
systems that may contain eTMF data
14
How the
regulators
will inspect
eTMF
15. 15
POLL
A B O U T T H E C O M P A N Y
Have you undergone an inspection that
involved your eTMF?
• Yes and I provided guided access
• Yes and the inspector accessed the
eTMF directly
• No, we have never been inspected or
were inspected using paper
16. Documents
vs Data
how to
manage
• Recent inspection in the UK identified over 40
electronic systems that contained data that were
relevant to the TMF
• More and more study information which could be
used to demonstrate compliance is contained within
other systems i.e.
- MVRs in CTMS
- Safety reports in PVS
- SAE data in EDC
• Need to clearly identify what you consider to be TMF
relevant in the inventory
• Ensure that you can provide access to information
contained within these systems to inspectors
17. Documents
vs Data
how to
manage
• Avoid producing PDF outputs of data if possible
or practical
• Evaluate ways of presenting information in a
more holistic way across systems
• Ensure that there is uniformity across systems in
relation to identifiers and metadata
• Ensure that you have a clear process for each of
the areas that is generating eTMF content
18. • Changing regulatory requirements and
expectations in relation to TMF
inspection readiness
• Increased complexity in study design
and study operations
• Benefit of centralizing content in one
location
• Ability to improve traceability and
execution of clinical processes
• Improved information management
and access
• Risk based clinical trials and clinical
metrics
18
What is
driving
eTMF
adoption
21. 0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
2011 2012 2013 2014 2015 2016 2017 2018
ResponsePercent
Survey year
What is the status of your eTMF/eISF?
We currently use eTMF / eISF
Evaluating
Actively Planning
Actively Building/Implementing
Not Considering
Not Applicable / Unknown
22. 22
POLL
A B O U T T H E C O M P A N Y
What is the status of eTMF in your
organization:
1. We are still using paper
2. We have a hybrid paper/electronic TMF
3. We use our CROs eTMF
4. We are fully electronic
5. We don’t have a TMF
23. What are the
key challenges
• TMF complexity with many
stakeholders
• Cost of acquisition and implementation
of eTMF systems
• Ability to fully eradicate paper
• TMF completeness calculation
complexity
• Multiple repositories and systems hold
TMF content
• Organizational change
24. What does
the future
hold.....
24
• Documents will become data
• eTMF completeness and QC will
be data and event driven
• Standards for content and
metadata
• Improvements in eTMF content
interchange
• Remote inspections
26. 26
POLL
A B O U T T H E C O M P A N Y
In your opinion how long does it take
to fully implement an eTMF solution?
a) Less than a month
b) 1-3 months
c) 3-6 months
d) 6-12 months
e) More than a year
27. 27
Process
A B O U T T H E C O M P A N Y
• Try and keep requirements to the point and avoid
stating the obvious
• Decide if you are looking for a cloud based or on
premise solution
• Think about internal and external usage as well as
how inspectors will access the eTMF
Establish Clear
Requirements
Identify
vendors
Evaluate
systems Contract
Plan
Resources Implement
28. 28
Process
A B O U T T H E C O M P A N Y
• Try to keep the number of vendors to a minimum
• Establish high level criteria that you will use to
select the vendors for evaluation i.e. geographic
presence, level of eTMF specialization, company
size, high level system features (from product
literature), delivery model (cloud vs on premise)
Establish Clear
Requirements
Identify
vendors
Evaluate
systems Contract
Plan
Resources Implement
29. 29
Process
A B O U T T H E C O M P A N Y
• Establish objective criteria based on system
functionality and alignment with your future
process
• Avoid complex scoring schemes based on
requirements
• Involve the right people to evaluate
• Ask vendors to show how your process would
look (avoid too many scenarios)
Establish Clear
Requirements
Identify
vendors
Evaluate
systems Contract
Plan
Resources Implement
30. 30
Process
A B O U T T H E C O M P A N Y
• Ensure that roles and responsibilities are clearly
defined
• Ensure storage limits and costs are clearly defined
especially in relation to archiving
• Perform adequate due diligence before signing
contracts
• Pre-agree deployment and go-live timeline
Establish Clear
Requirements
Identify
vendors
Evaluate
systems Contract
Plan
Resources Implement
31. 31
Process
A B O U T T H E C O M P A N Y
• Remember that system implementation is a group
effort between the vendor and your team
• Ensure that you have champions, super users and IT
involved in implementation
• Budget for internal resources and secure availability
• Assign an internal project manager to keep things
moving on your end
Establish Clear
Requirements
Identify
vendors
Evaluate
systems Contract
Plan
Resources Implement
32. 32
Process
A B O U T T H E C O M P A N Y
• Consider selecting a pilot project so that you can iron
out the kinks before deploying on a larger scale
• Try and adopt the TMF RM as much as possible
• Think carefully about TMF artifacts and what will be
managed in the eTMF solution versus other systems
• Aim to use the solution both internally and externally so
that all eTMF content is in one place
Establish Clear
Requirements
Identify
vendors
Evaluate
systems Contract
Plan
Resources Implement
33. 33
POLL
A B O U T T H E C O M P A N Y
Do you currently have a TMF
Champion in your organization?
a) Yes
b) No
34. 34
Key
attributes to
look for
• Ease of use for all stakeholders
• Flexibility to accommodate different study types
and ability to configure
• TMF auto-classification and fast indexing tools
• Use of TMF RM out of the box
• Ability to evaluate TMF completeness based on
study status and design
• Inspector mode (easy search, review and
tagging)
• Ability to centralize platform for use by all
stakeholders
35. 35
Right sizing
the vendor
• Not all vendors are created equal
• Look for vendors that can support your volume of
business
• Prefer vendors with sound industry knowledge
• Evaluate vendors product roadmap and their
product evolution
• Choose the vendor that best fits your process
and budget
• Look for a business partner type relationship
where you are able to contribute to the evolution
of the product
37. 37
Plan
• Have an overall, sustainable strategy: internal implementation needs
• Study assessment in the eTMF
• Change and culture management
• TMF Reference Model mapping
• Go Live!
38. 38
Strategy
Needs Assessment:
• How soon do you need the eTMF to be implemented? Do you have enough
time?
• Understand current TMF document and content location;
• Evaluate if it is possible to bring everything into one system;
• According to the 2015 TMF Reference Model survey, 42% are still using
multiple repositories
• Potential Issues: multiple SOPs, multiple people, easily out of compliance
– not knowing where documents are could raise red flags
39. 39
Assessment
• Clinical trial assessment which studies will utilize the eTMF
technology
• Start with a pilot! A new study that can start in the eTMF
• TMF Migration
§ All studies
§ Risk Based approach
§ Hybrid
40. 40
Change is inevitable
• Culture and change management
• What are your organizations values, believes and norms toward the TMF?
• TMF Champion
• Innovator: renew the TMF through technology, people and process;
• Committed to Change: shepherd organizational change despite opposition;
• New Processes: align with eTMF (technology) and people;
• Change Management Network: within each department to help cascade and support the
change
“You must remain focused on your journey to greatness” Les Brown
41. 41
TMF RM Adoption
• Master TMF Plan: how your organization will file TMF content
• SOP Mapping: understand the required documents (Regulatory
requirements, ICH GCP and your organizations SOPs)
• Naming Conventions: how will documents be named in the eTMF
system
• Date Conventions: consistent way to associate dates to documents
• TMF Plan: study specific conventions and requirements
42. 42
Ready, Set, Go!
• Properly manage the implementation process from concept through
completion
• Control the process
• Don’t be shy – you can change stuff – break things down – people,
process and technology
• Checkpoints along the way!
43. 43
Conclusions & Recommendations
• Have a deep understanding the of regulatory environment
• eTMF vendor selection – choose the one that is right for you!
• Timelines and milestones should be achievable
• Have a plan and be ready for Day 1
• Ask for help when needed
44. 44
• Facilitates exchange of clinical trial
information to all stakeholders
• Accurately tracks the progress of
TMF completeness
• Allows you to quickly comply with
regulatory requirements, audits and
inspections
An intuitive eTMF
Platform Engineered for
Growth Organizations
45. Are you interested in receiving
more information about
Montrium’s eTMF Connect?
1) Yes, could be useful
2) No, not interested
45
POLL